Label-free quantitative urinary proteomics identifies the arginase pathway as a new player in congenital obstructive nephropathy

Molecular and Cellular Proteomics

Volumn 13, Issue 12, 2014, Pages 3421-3434

  Lacroix, Chrystelle ^a,b   Caubet, Cécile ^b,c   Gonzalez De Peredo, Anne ^a,b   Breuil, Benjamin ^b,c   Bouyssié, David ^a,b   Stella, Alexandre ^a,b   Garrigues, Luc ^a,b   Le Gall, Caroline ^d,e   Raevel, Anthony ^b,c   Massoubre, Angelique ^b,c   Klein, Julie ^b,c   Decramer, Stéphane ^b,c,f   Sabourdy, Frédérique ^g   Bandin, Flavio ^b,c,f   Burlet Schiltz, Odile ^a,b   Monsarrat, Bernard ^a,b   Schanstra, Joost Peter ^b,c   Bascands, Jean Loup ^b,c  

^a CNRS   (France)

^b UNIVERSITÉ PAUL SABATIER   (France)

^c INSERM   (France)

^d Methodomics   (France)

^e UNIVERSITÉ DE TOULOUSE   (France)

^f HÔPITAL DES ENFANTS   (France)

^g CHU PURPAN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINASE; ARGINASE 1; ARGINASE 2; MESSENGER RNA; PROTEOME; UNCLASSIFIED DRUG; ARGINASE I, HUMAN; ARGINASE II, HUMAN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLINICAL ARTICLE; CONGENITAL OBSTRUCTIVE NEPHROPATHY; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; IN VIVO STUDY; KIDNEY MALFORMATION; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; MOUSE; MULTIPLE REACTION MONITORING MASS SPECTROMETRY; NANOANALYSIS; NEWBORN; NEWBORN DISEASE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN URINE LEVEL; PROTEOMICS; QUANTITATIVE ANALYSIS; TANDEM MASS SPECTROMETRY; URINALYSIS; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; HYDRONEPHROSIS; INFANT; KIDNEY; METABOLISM; PATHOLOGY; PROCEDURES; RENAL INSUFFICIENCY; SIGNAL TRANSDUCTION; URINE;

ANIMALS; ARGINASE; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; HUMANS; HYDRONEPHROSIS; INFANT; INFANT, NEWBORN; KIDNEY; MALE; MICE, INBRED C57BL; PROTEOME; PROTEOMICS; RENAL INSUFFICIENCY; SIGNAL TRANSDUCTION;

EID: 84928266354     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M114.040121     Document Type: Article

References (70)

1. Harambat, J., van Stralen, K. J., Kim, J. J., and Tizard, E. J. (2012) Epidemiology of chronic kidney disease in children. Pediatr. Nephrol. 27, 363-373
2. Heinlen, J. E., Manatt, C. S., Bright, B. C., Kropp, B. P., Campbell, J. B., and Frimberger, D. (2009) Operative versus nonoperative management of ureteropelvic junction obstruction in children. Urology 73, 521-525; discussion 525
3. Decramer, S., Bascands, J. L., and Schanstra, J. P. (2007) Noninvasive markers of ureteropelvic junction obstruction. World J. Urol. 25, 457-465
4. Klein, J., Gonzalez, J., Miravete, M., Caubet, C., Chaaya, R., Decramer, S., Bandin, F., Bascands, J. L., Buffin-Meyer, B., and Schanstra, J. P. (2011) Congenital ureteropelvic junction obstruction: human disease and animal models. Int. J. Exp. Pathol. 92, 168-192
5. Decramer, S., Gonzalez de Peredo, A., Breuil, B., Mischak, H., Monsarrat, B., Bascands, J. L., and Schanstra, J. P. (2008) Urine in clinical proteomics. Mol. Cell. Proteomics 7, 1850-1862
6. Hanash, S. (2003) Disease proteomics. Nature 422, 226-232
7. Drube, J., Zurbig, P., Schiffer, E., Lau, E., Ure, B., Gluer, S., Kirschstein, M., Pape, L., Decramer, S., Bascands, J. L., Schanstra, J. P., Mischak, H., and Ehrich, J. H. (2010) Urinary proteome analysis identifies infants but not older children requiring pyeloplasty. Pediatr. Nephrol. 25, 1673-1678
8. Patel, K., Charron, M., Hoberman, A., Brown, M. L., and Rogers, K. D. (1993) Intra- and interobserver variability in interpretation of DMSA scans using a set of standardized criteria. Pediatr. Radiol. 23, 506-509
9. MacKenzie, J. R. (1996) A review of renal scarring in children. Nucl. Med. Commun. 17, 176-190
10. Decramer, S., Wittke, S., Mischak, H., Zurbig, P., Walden, M., Bouissou, F., Bascands, J. L., and Schanstra, J. P. (2006) Predicting the clinical outcome of congenital unilateral ureteropelvic junction obstruction in newborn by urinary proteome analysis. Nat. Med. 12, 398-400
11. Smith, G., Barratt, D., Rowlinson, R., Nickson, J., and Tonge, R. (2005) Development of a high-throughput method for preparing human urine for two-dimensional electrophoresis. Proteomics 5, 2315-2318
12. Zerefos, P. G., Vougas, K., Dimitraki, P., Kossida, S., Petrolekas, A., Stravodimos, K., Giannopoulos, A., Fountoulakis, M., and Vlahou, A. (2006) Characterization of the human urine proteome by preparative electrophoresis in combination with 2-DE. Proteomics 6, 4346-4355
13. Adachi, J., Kumar, C., Zhang, Y., Olsen, J. V., and Mann, M. (2006) The human urinary proteome contains more than 1500 proteins, including a large proportion of membrane proteins. Genome Biol. 7, R80
14. Castagna, A., Cecconi, D., Sennels, L., Rappsilber, J., Guerrier, L., Fortis, F., Boschetti, E., Lomas, L., and Righetti, P. G. (2005) Exploring the hidden human urinary proteome via ligand library beads. J. Proteome Res. 4, 1917-1930
15. Kentsis, A., Monigatti, F., Dorff, K., Campagne, F., Bachur, R., and Steen, H. (2009) Urine proteomics for profiling of human disease using high accuracy mass spectrometry. Proteomics Clin. Appl. 3, 1052-1061
16. Marimuthu, A., O'Meally, R. N., Chaerkady, R., Subbannayya, Y., Nanjappa, V., Kumar, P., Kelkar, D. S., Pinto, S. M., Sharma, R., Renuse, S., Goel, R., Christopher, R., Delanghe, B., Cole, R. N., Harsha, H. C., and Pandey, A. (2011) A comprehensive map of the human urinary proteome. J. Proteome Res. 10, 2734-2743
17. Wong, J. C., Rossleigh, M. A., and Farnsworth, R. H. (1995) Utility of technetium-99m-MAG3 diuretic renography in the neonatal period. J. Nucl. Med. 36, 2214-2219
18. Grignon, A., Filion, R., Filiatrault, D., Robitaille, P., Homsy, Y., Boutin, H., and Leblond, R. (1986) Urinary tract dilatation in utero: classification and clinical applications. Radiology 160, 645-647
19. Fernbach, S. K., Maizels, M., and Conway, J. J. (1993) Ultrasound grading of hydronephrosis: introduction to the system used by the Society for Fetal Urology. Pediatr. Radiol. 23, 478-480
20. Maizels, M., Mitchell, B., Kass, E., Fernbach, S. K., and Conway, J. J. (1994) Outcome of nonspecific hydronephrosis in the infant: a report from the Registry of the Society for Fetal Urology. J. Urol. 152, 2324-2327
21. Wisniewski, J. R., Zougman, A., Nagaraj, N., and Mann, M. (2009) Universal sample preparation method for proteome analysis. Nat. Methods 6, 359-362
22. Wisniewski, J. R., Ostasiewicz, P., and Mann, M. (2011) High recovery FASP applied to the proteomic analysis of microdissected formalin fixed paraffin embedded cancer tissues retrieves known colon cancer markers. J. Proteome Res. 10, 3040-3049
23. Benjamini, Y., Drai, D., Elmer, G., Kafkafi, N., and Golani, I. (2001) Controlling the false discovery rate in behavior genetics research. Behav. Brain Res. 125, 279-284
24. Mani, D. R., Abbatiello, S. E., and Carr, S. A. (2012) Statistical characterization of multiple-reaction monitoring mass spectrometry (MRM-MS) assays for quantitative proteomics. BMC Bioinformatics 16, S9
25. Abbatiello, S. E., Mani, D. R., Keshishian, H., and Carr, S. A. (2010) Automated detection of inaccurate and imprecise transitions in peptide quantification by multiple reaction monitoring mass spectrometry. Clin. Chem. 56, 291-305
26. Bascands, J. L., and Schanstra, J. P. (2005) Obstructive nephropathy: insights from genetically engineered animals. Kidney Int. 68, 925-937
27. Chevalier, R. L., Forbes, M. S., and Thornhill, B. A. (2009) Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy. Kidney Int. 75, 1145-1152
28. Schanstra, J. P., Neau, E., Drogoz, P., Arevalo Gomez, M. A., Lopez Novoa, J. M., Calise, D., Pecher, C., Bader, M., Girolami, J. P., and Bascands, J. L. (2002) In vivo bradykinin B2 receptor activation reduces renal fibrosis. J. Clin. Invest. 110, 371-379
29. del Ara, R. M., Gonzalez-Polo, R. A., Caro, A., del Amo, E., Palomo, L., Hernandez, E., Soler, G., and Fuentes, J. M. (2002) Diagnostic performance of arginase activity in colorectal cancer. Clin. Exp. Med. 2, 53-57
30. Nagaraj, N., and Mann, M. (2011) Quantitative analysis of the intra- and inter-individual variability of the normal urinary proteome. J. Proteome Res. 10, 637-645
31. Court, M., Selevsek, N., Matondo, M., Allory, Y., Garin, J., Masselon, C. D., and Domon, B. (2011) Toward a standardized urine proteome analysis methodology. Proteomics 11, 1160-1171
32. Mouton-Barbosa, E., Roux-Dalvai, F., Bouyssie, D., Berger, F., Schmidt, E., Righetti, P. G., Guerrier, L., Boschetti, E., Burlet-Schiltz, O., Monsarrat, B., and Gonzalez de Peredo, A. (2010) In-depth exploration of cerebrospinal fluid by combining peptide ligand library treatment and label-free protein quantification. Mol. Cell. Proteomics 9, 1006-1021
33. Grandaliano, G., Gesualdo, L., Bartoli, F., Ranieri, E., Monno, R., Leggio, A., Paradies, G., Caldarulo, E., Infante, B., and Schena, F. P. (2000) MCP-1 and EGF renal expression and urine excretion in human congenital obstructive nephropathy. Kidney Int. 58, 182-192
34. Yang, Y., Hou, Y., Wang, C. L., and Ji, S. J. (2006) Renal expression of epidermal growth factor and transforming growth factor-beta1 in children with congenital hydronephrosis. Urology 67, 817-821; discussion 821-812
35. Mischak, H., Allmaier, G., Apweiler, R., Attwood, T., Baumann, M., Benigni, A., Bennett, S. E., Bischoff, R., Bongcam-Rudloff, E., Capasso, G., Coon, J. J., D'Haese, P., Dominiczak, A. F., Dakna, M., Dihazi, H., Ehrich, J. H., Fernandez-Llama, P., Fliser, D., Frokiaer, J., Garin, J., Girolami, M., Hancock, W. S., Haubitz, M., Hochstrasser, D., Holman, R. R., Ioannidis, J. P., Jankowski, J., Julian, B. A., Klein, J. B., Kolch, W., Luider, T., Massy, Z., Mattes, W. B., Molina, F., Monsarrat, B., Novak, J., Peter, K., Rossing, P., Sanchez-Carbayo, M., Schanstra, J. P., Semmes, O. J., Spasovski, G., Theodorescu, D., Thongboonkerd, V., Vanholder, R., Veenstra, T. D., Weissinger, E., Yamamoto, T., and Vlahou, A. (2010) Recommendations for biomarker identification and qualification in clinical proteomics. Sci. Transl. Med. 2, 46ps42
36. Mischak, H., Apweiler, R., Banks, R. E., Conaway, M., Coon, J., Dominiczak, A., Ehrich, J. H., Fliser, D., Girolami, M., Hermjakob, H., Hochstrasser, D., Jankowski, J., Julian, B. A., Kolch, W., Massy, Z. A., Neusuess, C., Novak, J., Peter, K., Rossing, K., Schanstra, J., Semmes, O. J., Theodorescu, D., Thongboonkerd, V., Weissinger, E. M., Van Eyk, J. E., and Yamamoto, T. (2007) Clinical proteomics: a need to define the field and to begin to set adequate standards. Proteomics Clin. Appl. 1, 148-156
37. Cederbaum, S. D., Yu, H., Grody, W. W., Kern, R. M., Yoo, P., and Iyer, R. K. (2004) Arginases I and II: do their functions overlap? Mol. Genet. Metab. 1, S38-44
38. Goo, Y. A., Cain, K., Jarrett, M., Smith, L., Voss, J., Tolentino, E., Tsuji, J., Tsai, Y. S., Panchaud, A., Goodlett, D. R., Shulman, R. J., and Heitkemper, M. (2012) Urinary proteome analysis of irritable bowel syndrome (IBS) symptom subgroups. J. Proteome Res. 11, 5650-5662
39. Kentsis, A., Shulman, A., Ahmed, S., Brennan, E., Monuteaux, M. C., Lee, Y. H., Lipsett, S., Paulo, J. A., Dedeoglu, F., Fuhlbrigge, R., Bachur, R., Bradwin, G., Arditi, M., Sundel, R. P., Newburger, J. W., Steen, H., and Kim, S. (2013) Urine proteomics for discovery of improved diagnostic markers of Kawasaki disease. EMBO Mol. Med. 5, 210-220
40. Wright, C. A., Howles, S., Trudgian, D. C., Kessler, B. M., Reynard, J. M., Noble, J. G., Hamdy, F. C., and Turney, B. W. (2011) Label-free quantitative proteomics reveals differentially regulated proteins influencing urolithiasis. Mol. Cell. Proteomics 10, M110 005686
41. Zoidakis, J., Makridakis, M., Zerefos, P. G., Bitsika, V., Esteban, S., Frantzi, M., Stravodimos, K., Anagnou, N. P., Roubelakis, M. G., Sanchez-Carbayo, M., and Vlahou, A. (2012) Profilin 1 is a potential biomarker for bladder cancer aggressiveness. Mol. Cell. Proteomics 11, M111 009449
42. Lee, R. S., Monigatti, F., Briscoe, A. C., Waldon, Z., Freeman, M. R., and Steen, H. (2008) Optimizing sample handling for urinary proteomics. J. Proteome Res. 7, 4022-4030
43. Thongboonkerd, V. (2007) Practical points in urinary proteomics. J. Proteome Res. 6, 3881-3890
44. Chen, C. L., Lai, Y. F., Tang, P., Chien, K. Y., Yu, J. S., Tsai, C. H., Chen, H. W., Wu, C. C., Chung, T., Hsu, C. W., Chen, C. D., Chang, Y. S., Chang, P. L., and Chen, Y. T. (2012) Comparative and targeted proteomic analyses of urinary microparticles from bladder cancer and hernia patients. J. Proteome Res. 11, 5611-5629
45. Chen, Y. T., Chen, H. W., Domanski, D., Smith, D. S., Liang, K. H., Wu, C. C., Chen, C. L., Chung, T., Chen, M. C., Chang, Y. S., Parker, C. E., Borchers, C. H., and Yu, J. S. (2012) Multiplexed quantification of 63 proteins in human urine by multiple reaction monitoring-based mass spectrometry for discovery of potential bladder cancer biomarkers. J. Proteomics 75, 3529-3545
46. Huttenhain, R., Soste, M., Selevsek, N., Rost, H., Sethi, A., Carapito, C., Farrah, T., Deutsch, E. W., Kusebauch, U., Moritz, R. L., Nimeus-Malmstrom, E., Rinner, O., and Aebersold, R. (2012) Reproducible quantification of cancer-associated proteins in body fluids using targeted proteomics. Sci. Transl. Med. 4, 142ra194
47. Li, Z., Zhao, Z., Liu, X., Su, Z., Shang, X., and Wen, J. (2012) Prediction of the outcome of antenatal hydronephrosis: significance of urinary EGF. Pediatr. Nephrol. 27, 2251-2259
48. Thongboonkerd, V., and Malasit, P. (2005) Renal and urinary proteomics: current applications and challenges. Proteomics 5, 1033-1042
49. Schwartz, I. F., Davidovitz, A., Chernichovski, T., Levin-Iaina, N., Guzner-Gur, H., Levo, Y., and Schwartz, D. (2008) Arginine transport is augmented, through modulation of cationic amino acid transporter-1, in obstructive uropathy in rats. Kidney Blood Press. R. 31, 210-216
50. Wu, G., and Morris, S. M., Jr. (1998) Arginine metabolism: nitric oxide and beyond. Biochem. J. 336, 1-17
51. Morris, S. M., Jr. (2007) Arginine metabolism: boundaries of our knowledge. J. Nutr. 137, 1602S-1609S
52. Ming, X. F., Rajapakse, A. G., Yepuri, G., Xiong, Y., Carvas, J. M., Ruffieux, J., Scerri, I., Wu, Z., Popp, K., Li, J., Sartori, C., Scherrer, U., Kwak, B. R., Montani, J. P., and Yang, Z. (2012) Arginase II promotes macrophage inflammatory responses through mitochondrial reactive oxygen species, contributing to insulin resistance and atherogenesis. J. Am. Heart Assoc. 1, e000992
53. Morris, S. M., Jr., Gao, T., Cooper, T. K., Kepka-Lenhart, D., and Awad, A. S. (2011) Arginase-2 mediates diabetic renal injury. Diabetes 60, 3015-3022
54. Gronros, J., Jung, C., Lundberg, J. O., Cerrato, R., Ostenson, C. G., and Pernow, J. (2011) Arginase inhibition restores in vivo coronary microvascular function in type 2 diabetic rats. Am. J. Physiol. Heart Circ. Physiol. 300, H1174-H1181
55. Olivon, V. C., Fraga-Silva, R. A., Segers, D., Demougeot, C., de Oliveira, A. M., Savergnini, S. S., Berthelot, A., de Crom, R., Krams, R., Stergiopulos, N., and da Silva, R. F. (2013) Arginase inhibition prevents the low shear stress-induced development of vulnerable atherosclerotic plaques in ApoE-/- mice. Atherosclerosis 227, 236-243
56. Maarsingh, H., Pera, T., and Meurs, H. (2008) Arginase and pulmonary diseases. Naunyn Schmiedebergs Arch. Pharmacol. 378, 171-184
57. Bratt, J. M., Franzi, L. M., Linderholm, A. L., O'Roark, E. M., Kenyon, N. J., and Last, J. A. (2010) Arginase inhibition in airways from normal and nitric oxide synthase 2-knockout mice exposed to ovalbumin. Toxicol. Appl. Pharmacol. 242, 1-8
58. Durante, W., Johnson, F. K., and Johnson, R. A. (2007) Arginase: a critical regulator of nitric oxide synthesis and vascular function. Clin. Exp. Pharmacol. Physiol. 34, 906-911
59. Mori, M. (2007) Regulation of nitric oxide synthesis and apoptosis by arginase and arginine recycling. J. Nutr. 137, 1616S-1620S
60. Morrissey, J. J., Ishidoya, S., McCracken, R., and Klahr, S. (1996) Nitric oxide generation ameliorates the tubulointerstitial fibrosis of obstructive nephropathy. J. Am. Soc. Nephrol. 7, 2202-2212
61. Miyajima, A., Chen, J., Poppas, D. P., Vaughan, E. D., Jr., and Felsen, D. (2001) Role of nitric oxide in renal tubular apoptosis of unilateral ureteral obstruction. Kidney Int. 59, 1290-1303
62. Manucha, W., and Valles, P. G. (2008) Cytoprotective role of nitric oxide associated with Hsp70 expression in neonatal obstructive nephropathy. Nitric Oxide 18, 204-215
63. You, H., Gao, T., Cooper, T. K., Morris, S. M., Jr., and Awad, A. S. (2013) Arginase inhibition mediates renal tissue protection in diabetic nephropathy by a nitric oxide synthase 3-dependent mechanism. Kidney Int. 84, 1189-1197
64. Yang, Z., and Ming, X. F. (2013) Arginase: the emerging therapeutic target for vascular oxidative stress and inflammation. Front Immunol. 4, 149
65. Kitowska, K., Zakrzewicz, D., Konigshoff, M., Chrobak, I., Grimminger, F., Seeger, W., Bulau, P., and Eickelberg, O. (2008) Functional role and species-specific contribution of arginases in pulmonary fibrosis. Am. J. Physiol-Lung C. 294, L34-L45
66. Endo, M., Oyadomari, S., Terasaki, Y., Takeya, M., Suga, M., Mori, M., and Gotoh, T. (2003) Induction of arginase I and II in bleomycin-induced fibrosis of mouse lung. Am. J. Physiol-Lung C. 285, L313-L321
67. Ozaki, M., Gotoh, T., Nagasaki, A., Miyanaka, K., Takeya, M., Fujiyama, S., Tomita, K., and Mori, M. (1999) Expression of arginase II and related enzymes in the rat small intestine and kidney. J. Biochem. 125, 586-593
68. Spector, E. B., Rice, S. C., and Cederbaum, S. D. (1983) Immunologic studies of arginase in tissues of normal human adult and arginasedeficient patients. Pediatr. Res. 17, 941-944
69. Choi, S., Park, C., Ahn, M., Lee, J. H., and Shin, T. (2012) Immunohistochemical study of arginase 1 and 2 in various tissues of rats. Acta Histochem. 114, 487-494
70. Crombez, E. A., and Cederbaum, S. D. (2005) Hyperargininemia due to liver arginase deficiency. Mol. Genet. Metab. 84, 243-251